3 Examples of the Potential in IBM's Watson

3 Examples of the Potential in IBM's Watson

The face of International Business Machines‘ (NYSE:IBM) transformation is Watson. Bursting onto the scene in 2011 by winning a game of Jeopardy!, IBM's cognitive computing system is now being used in a wide variety of industries to boost efficiency and cut costs. The company predicts that 1 billion people will use Watson, either directly or → Read More

Is CSX Corporation Stock Gearing Up for Another Huge Year After a Fantastic 2016?

Is CSX Corporation Stock Gearing Up for Another Huge Year After a Fantastic 2016?

CSX Corporation (NASDAQ:CSX) has faced a confluence of challenges in recent years, with low commodity prices and the secular decline in coal proving particularly detrimental to the railroad's prospects. 2016, however, turned out to be a surprisingly strong year, with CSX stock soaring 39% as commodity prices bottomed out. Any recovery in end markets, however, → Read More

These 3 Stocks Could Boost Their Dividends in 2017

These 3 Stocks Could Boost Their Dividends in 2017

High-dividend yields may be tempting in today's interest-rate environment, but investing in dividend growth stocks is an even better way to boost your income and build your wealth in the long run. As companies usually increase their dividends when they're confident about their growth prospects, investing in such stocks also offers strong capital appreciation potential → Read More

Say goodbye to this classic Monopoly token

Say goodbye to this classic Monopoly token

Your next monopoly game piece could be a hashtag Monopoly fans cast four million votes last month to decide which of the board game's classic eight tokens should stay around — and which gets the ax. The results are in: Say goodbye to the thimble. This means that the thimble token — which has been → Read More

Why Edwards Lifesciences Could Bounce Back

Why Edwards Lifesciences Could Bounce  Back

In the past, surgeons had to conduct open heart surgery to replace narrowing arteries in a patient's heart. Thanks to innovation at Edwards Lifesciences (NYSE:EW), a growing number of those patients are getting a less invasive surgery called transcatheter aortic valve replacement (TAVR). The rising adoption of TAVR propelled Edwards Lifesciences' shares up 231% between → Read More

Canada Goose: Maker of $1,000 parkas files for IPO

Canada Goose: Maker of $1,000 parkas files for IPO

The cost of winter storms Canada Goose has built a business around selling parkas for north of $1,000. Up next: Selling investors on an IPO. The family-run firm announced on Wednesday that it's planning to list shares on the New York Stock Exchange and Toronto Stock Exchange under the ticker symbol “GOOS”. Read More

3 Things to Watch When Home Depot Inc Posts Earnings Next Week

3 Things to Watch When Home Depot Inc Posts Earnings Next Week

Home Depot (NYSE:HD) is set to report its fourth-quarter earnings results before the market opens on Tuesday, Feb. 21. Judging by the stock's run toward record highs after trailing the market in 2016, investors are growing more optimistic about its home improvement business. Below, I'll highlight the important trends that might add to that positive → Read More

Snapchat's IPO has a Twitter problem

Snapchat's IPO has a Twitter problem

An afternoon with Snap Spectacles One week after Snapchat's parent company filed paperwork for its long-awaited IPO, Twitter released yet another disappointing earnings report that tanked its stock. The two events might seem unrelated, but Twitter's struggles are perhaps the clearest reminder to potential Snap Inc investors of the risk in backing flashy social media → Read More

Amazon Plans to Drop Packages With Parachutes From Drones

Amazon Plans to Drop Packages With Parachutes From Drones

Amazon (NASDAQ:AMZN) has long teased consumers with the idea that it would someday deliver packages via drones. The company has pursued the idea even though it's not currently legal to use unmanned flying vehicles for most commercial activities (including package delivery) in the United States. And while that could eventually change, the Federal Aviation Administration → Read More

3 Signs FireEye Inc's High Growth Days Are Over

3 Signs FireEye Inc's High Growth Days Are Over

Cyber security specialist FireEye‘s (NASDAQ:FEYE) is becoming more financially fit. Last quarter, the company came within just $2 million of posting positive operating earnings on a non-GAAP basis. It also returned to positive cash flow despite big charges related to its restructuring efforts. However, investors ignored that good news and sent the stock sharply lower following → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.